176 related articles for article (PubMed ID: 22206251)
1. CD93: recent advances and implications in disease.
Greenlee-Wacker MC; Galvan MD; Bohlson SS
Curr Drug Targets; 2012 Mar; 13(3):411-20. PubMed ID: 22206251
[TBL] [Abstract][Full Text] [Related]
2. Soluble expression of disulfide-bonded C-type lectin like domain of human CD93 in the cytoplasm of Escherichia coli.
Nativel B; Figuester A; Andries J; Planesse C; Couprie J; Gasque P; Viranaicken W; Iwema T
J Immunol Methods; 2016 Dec; 439():67-73. PubMed ID: 27742562
[TBL] [Abstract][Full Text] [Related]
3. CD93 regulates central nervous system inflammation in two mouse models of autoimmune encephalomyelitis.
Griffiths MR; Botto M; Morgan BP; Neal JW; Gasque P
Immunology; 2018 Nov; 155(3):346-355. PubMed ID: 29923617
[TBL] [Abstract][Full Text] [Related]
4. CD93 and related family members: their role in innate immunity.
Greenlee MC; Sullivan SA; Bohlson SS
Curr Drug Targets; 2008 Feb; 9(2):130-8. PubMed ID: 18288964
[TBL] [Abstract][Full Text] [Related]
5. Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis.
Norsworthy PJ; Fossati-Jimack L; Cortes-Hernandez J; Taylor PR; Bygrave AE; Thompson RD; Nourshargh S; Walport MJ; Botto M
J Immunol; 2004 Mar; 172(6):3406-14. PubMed ID: 15004139
[TBL] [Abstract][Full Text] [Related]
6. CD93/AA4.1: a novel regulator of inflammation in murine focal cerebral ischemia.
Harhausen D; Prinz V; Ziegler G; Gertz K; Endres M; Lehrach H; Gasque P; Botto M; Stahel PF; Dirnagl U; Nietfeld W; Trendelenburg G
J Immunol; 2010 Jun; 184(11):6407-17. PubMed ID: 20439917
[TBL] [Abstract][Full Text] [Related]
7. Decrease in CD93 (C1qRp) expression in a human monocyte-like cell line (U937) treated with various apoptosis-inducing chemical substances.
Ikewaki N; Tamauchi H; Inoko H
Microbiol Immunol; 2007; 51(12):1189-200. PubMed ID: 18094537
[TBL] [Abstract][Full Text] [Related]
8. Immune function of C1q and its modulators CD91 and CD93.
Tarr J; Eggleton P
Crit Rev Immunol; 2005; 25(4):305-30. PubMed ID: 16167883
[TBL] [Abstract][Full Text] [Related]
9. Regulation of CD93 cell surface expression by protein kinase C isoenzymes.
Ikewaki N; Kulski JK; Inoko H
Microbiol Immunol; 2006; 50(2):93-103. PubMed ID: 16490927
[TBL] [Abstract][Full Text] [Related]
10. CD93 is rapidly shed from the surface of human myeloid cells and the soluble form is detected in human plasma.
Bohlson SS; Silva R; Fonseca MI; Tenner AJ
J Immunol; 2005 Jul; 175(2):1239-47. PubMed ID: 16002728
[TBL] [Abstract][Full Text] [Related]
11. CD93 interacts with the PDZ domain-containing adaptor protein GIPC: implications in the modulation of phagocytosis.
Bohlson SS; Zhang M; Ortiz CE; Tenner AJ
J Leukoc Biol; 2005 Jan; 77(1):80-9. PubMed ID: 15459234
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium.
Galvagni F; Nardi F; Spiga O; Trezza A; Tarticchio G; Pellicani R; Andreuzzi E; Caldi E; Toti P; Tosi GM; Santucci A; Iozzo RV; Mongiat M; Orlandini M
Matrix Biol; 2017 Dec; 64():112-127. PubMed ID: 28912033
[TBL] [Abstract][Full Text] [Related]
13. Modulated interaction of the ERM protein, moesin, with CD93.
Zhang M; Bohlson SS; Dy M; Tenner AJ
Immunology; 2005 May; 115(1):63-73. PubMed ID: 15819698
[TBL] [Abstract][Full Text] [Related]
14. Detection and characterization of soluble CD93 released during inflammation.
Greenlee MC; Sullivan SA; Bohlson SS
Inflamm Res; 2009 Dec; 58(12):909-19. PubMed ID: 19603257
[TBL] [Abstract][Full Text] [Related]
15. Cell surface expression of C1qRP/CD93 is stabilized by O-glycosylation.
Park M; Tenner AJ
J Cell Physiol; 2003 Sep; 196(3):512-22. PubMed ID: 12891708
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.
Langenkamp E; Zhang L; Lugano R; Huang H; Elhassan TE; Georganaki M; Bazzar W; Lööf J; Trendelenburg G; Essand M; Pontén F; Smits A; Dimberg A
Cancer Res; 2015 Nov; 75(21):4504-16. PubMed ID: 26363010
[TBL] [Abstract][Full Text] [Related]
17. Identification of human CD93 as the phagocytic C1q receptor (C1qRp) by expression cloning.
Steinberger P; Szekeres A; Wille S; Stöckl J; Selenko N; Prager E; Staffler G; Madic O; Stockinger H; Knapp W
J Leukoc Biol; 2002 Jan; 71(1):133-40. PubMed ID: 11781389
[TBL] [Abstract][Full Text] [Related]
18. CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.
Iwasaki M; Liedtke M; Gentles AJ; Cleary ML
Cell Stem Cell; 2015 Oct; 17(4):412-21. PubMed ID: 26387756
[TBL] [Abstract][Full Text] [Related]
19. CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration adhesion and migration.
Galvagni F; Nardi F; Maida M; Bernardini G; Vannuccini S; Petraglia F; Santucci A; Orlandini M
Oncotarget; 2016 Mar; 7(9):10090-103. PubMed ID: 26848865
[TBL] [Abstract][Full Text] [Related]
20. Potential of serum soluble CD93 as a biomarker for asthma in an ovalbumin-induced asthma murine model.
Park HJ; Oh EY; Park YH; Yang M; Park KH; Park JW; Lee JH
Biomarkers; 2018 Jul; 23(5):446-452. PubMed ID: 29498549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
